Role of MRI in screening women at high risk for breast cancer

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 5, 2006, Pages 964-970

  Lehman, Constance D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Breast screening recommendations; High risk screening; Magnetic resonance imaging; Sensitivity and specificity

Indexed keywords

BREAST BIOPSY; BREAST CANCER; CANCER RISK; CANCER SCREENING; DIAGNOSTIC VALUE; FEMALE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION;

BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MASS SCREENING; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS;

EID: 33750456983     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20752     Document Type: Review

References (25)

1. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:265-271.
2. World Health Organization. Principles and practices of screening for disease. Geneva: WHO; 1968.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
4. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-646.
5. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-689.
6. American Cancer Society. Cancer facts and figures: 2004. Atlanta, GA: American Cancer Society; 2004.
7. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103:1898-1905.
8. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 2005;92:9-15: discussion 15-16.
9. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-8476.
10. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-1325.
11. Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002;21:115-124.
12. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000;63:53-60.
13. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181:619-626.
14. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-437.
15. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769-1778.
16. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215:267-279.
17. Tilanus-Linthorst MM, Bartels CC, Obdeijn AI, Oudkerk M. Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 2000;36:514-519.
18. Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999;86:449-462.
19. American College of Radiology. ACR BI-RADS®. ACR breast imaging reporting and data system, breast imaging atlas. Reston, VA: American College of Radiology; 2003.
20. Delille JP, Slanetz PJ, Yen ED, Kopans DB, Garrido L. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 2005;11:236-241.
21. Tilanus-Linthorst MM, Kriege M, Boetes C, et al. Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 2005;41:1610-1617.
22. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer. 2005. CA Cancer J Clin 2005;55:31-44: quiz 55-36.
23. Regence. The Regence Group medical policy: MRI of the breast. 2004. http://www.regence.com/trgmedpol/radiology/rad43.html
24. Aetna. Aetna clinical policy bulletin: Breast MRI. 2004. http://www.aetna.com/cpb/data/cpba0105.html
25. Blue Cross-Blue Shield. Magnetic resonance imaging of the breast in screening women considered to be at high genetic risk of breast cancer. Blue Cross Blue Shield, 2003. http://www.bcbst.com/mpmanual/whstart.htm